A Knutsford-based company which produces magazines and digital marketing solutions for the life science and medical industry is poised to become one of the world’s fastest-growing scientific publishers, after achieving continued rapid year-on-year growth.
Texere Publishing – which also has an office in New York – grew revenue in the US by over 17% and globally by 11% to £5.6m during 2020. Meanwhile its digital department enjoyed a record year, with a 70% increase in its digital event services, a 108% rise in website advertising and a 50% jump in its direct email service.
Texere, which is backed by investors Mercia and AXM Venture Capital Limited, publishes titles including The Analytical Scientist, The Medicine Maker, The Ophthalmologist, The Pathologist and The Cannabis Scientist. Despite the challenges created by the pandemic, the company launched three new newsletter titles in 2020 – The COVID-19 Curator, The Cell + Gene Curator and The Cannabis + Cannabinoid Curator – while its journalists continued to report on the biggest issues facing the sector. The Analytical Scientist tackled the topic of racism in science while The Medicine Maker looked at the key decisions made by the Trump administration and what impact the Presidential election might have on the future of American healthcare.
Texere was founded in 2012 by Andrew Davies, the current CEO, and Tracey Peers, the current COO. It now employs 46 people in the UK and six in the US. Andrew Davies said: “The great thing about our team is their dedication and agility. We all came together during COVID and were determined to continue supporting our clients and our readers in the best way that we could, in spite of the challenges that the pandemic presented to us all. In some ways, the pandemic’s challenges fuelled our out of the box thinking and helped us to come up with new solutions. That creativity and accomplishment sets a nice framework for 2021 and our tenth anniversary next year.”
Dawn Tyler of Mercia said: “Texere’s success is all the more remarkable given the pandemic and the wider challenges that many publishers have faced in recent years. We were impressed with the team’s performance and look toward another year of successful growth in 2021.”
